Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial

de Bono, JS; Concin, N; Hong, DS; Thistlethwaite, FC; Machiels, JP; Arkenau, HT; Plummer, R; Jones, RH; Nielsen, D; Windfeld, K; Ghatta, S; Slomovitz, BM; Spicer, JF; Yachnin, J; Ang, JE; Mau-Srensen, PM; Forster, MD; Collins, D; Dean, E; Rangwala, R

de Bono, JS (reprint author), Royal Marsden NHS Fdn Trust, Inst Canc Res, Sutton SM2 5NG, Surrey, England.

LANCET ONCOLOGY, 2019; 20 (3): 383

Abstract

Background Tisotumab vedotin is a first-in-human antibody-drug conjugate directed against tissue factor, which is expressed across multiple solid tumo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索